What companies are TAK's competitors?

Takeda Pharmaceutical Company Limited (TAK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does TAK compare to its peers?

The peer comparison table on this page shows Takeda Pharmaceutical Company Limited (TAK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does TAK operate in?

Takeda Pharmaceutical Company Limited (TAK) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

TAK

Takeda Pharmaceutical Company Limited

NYSE·Drug Manufacturers, Specialty & Generic · Healthcare

$20.24$0.12−0.59%

Market cap$64.41B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About TAK

What companies are TAK's competitors?: Takeda Pharmaceutical Company Limited (TAK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does TAK compare to its peers?: The peer comparison table on this page shows Takeda Pharmaceutical Company Limited (TAK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does TAK operate in?: Takeda Pharmaceutical Company Limited (TAK) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

TAK

Takeda Pharmaceutical Company Limited

NYSE·Drug Manufacturers, Specialty & Generic · Healthcare

$20.24$0.12−0.59%

Market cap$64.41B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


LLYLLYEli Lilly and Company	Eli Lilly and Company	$1,273.46	$1.2T
MRKMRKMerck & Co., Inc.	Merck & Co., Inc.	$145.27	$358.4B
AZNAZNAstraZeneca PLC	AstraZeneca PLC	$171.49	$266.0B
AMGNAMGNAmgen Inc.	Amgen Inc.	$439.26	$237.5B
PFEPFEPfizer Inc.	Pfizer Inc.	$30.03	$171.2B
BMYBMYBristol-Myers Squibb Company	Bristol-Myers Squibb Company	$61.48	$125.6B
SNYSNYSanofi	Sanofi	$41.60	$100.8B
CHGCFCHGCFChugai Pharmaceutical Co., Ltd.	Chugai Pharmaceutical Co., Ltd.	$44.82	$73.8B
ALPMYALPMYAstellas Pharma Inc.	Astellas Pharma Inc.	$15.95	$28.6B
GRFSGRFSGrifols, S.A.	Grifols, S.A.	$7.56	$6.4B

Frequently Asked Questions About TAK

What companies are TAK's competitors?: Takeda Pharmaceutical Company Limited (TAK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does TAK compare to its peers?: The peer comparison table on this page shows Takeda Pharmaceutical Company Limited (TAK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does TAK operate in?: Takeda Pharmaceutical Company Limited (TAK) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.